Market Access/ News/ News/ News/ Oncology UroGen’s urothelial cancer drug bags FDA approval George Underwood Jelmyto, Urogen, urothelial cancer 0 Comment The FDA has approved UroGen’s Jelmyto (mitomycin gel) as the first therapy to treat low-grade upper tract urothelial Share X UroGen’s urothelial cancer drug bags FDA approval https://pharmaphorum.com/news/urogens-urothelial-cancer-drug-bags-fda-approval/
News/ News/ Oncology UroGen’s urothelial cancer drug hits target, could prevent surgery Richard Staines cancer, R&D, urothelial cancer 0 Comment Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have Share X UroGen’s urothelial cancer drug hits target, could prevent surgery https://pharmaphorum.com/news/urogens-urothelial-cancer-drug-hits-target-could-prevent-surgery/
News/ News/ Oncology UroGen appoints former Novartis cancer chief Barrett as CEO Richard Staines cancer, Liz Barrett, Urogen, urothelial cancer 0 Comment Novartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring Share X UroGen appoints former Novartis cancer chief Barrett as CEO https://pharmaphorum.com/news/urogen-appoints-former-novartis-cancer-chief-barrett-as-ceo/
